Rotator Cuff Injury Treatment market in terms of revenue was estimated to be worth $989.3 million in 2021 and is poised to reach $1,244.2 million by 2026, growing at a CAGR of 4.7% from 2021 to 2026 according to a latest report published by MarketsandMarkets™. Various factors such as rising number of sports-related shoulder injuries, technological advancements in rotator cuff rupture arthroscopic surgical devices, greater product affordability and market availability, and growing public awareness related to the availability of different treatments for rotator cuff rupture. Moreover, the ongoing developments in regenerative biologics are likely to offer significant growth opportunities for players in the rotator cuff injury treatment market.
Download an Illustrative overview:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=71095820
The in rotator cuff injury treatment market include major Tier I and II suppliers of in rotator cuff injury treatment devices are Arthrex (US), Stryker Corporation (US), Smith & Nephew (UK), Johnson & Johnson (DePuy Synthes) (US), Zimmer Biomet (US), CONMED Corporation (US), Integra Lifesciences Corporation (US), LimaCorporate (Italy), FH ORTHOPEDICS S.A.S. (France), Evolutis India Pvt Ltd. (India), DJO Global (US), 3S Ortho (France), Breg, Inc. (US), GPC Medical Ltd. (India), and Parcus Medical (US). These suppliers have their manufacturing facilities spread across regions such as North America, Europe, Asia Pacific.
The rise in number of arthroscopic surgical treatment and technological advancements in arthroscopic surgical devices in to support the market growth during the forecast period.”
Arthroscopy procedures are increasingly being recommended by physicians for rotator cuff repair owing to their clinical benefits such as minimally invasive procedures (in open rotator cuff repair surgeries, a two-to-three-inch incision is made as compared to less than one inch in arthroscopy-driven procedures). Furthermore, the increasing prevalence of rotator cuff injuries (especially among sportspersons) and the technological advancements in arthroscopic surgical devices are likely to boost the demand for shoulder arthroscopy for rotator cuff injury treatment.
Asia Pacific likely to emerge as the fastest-growing rotator cuff injury treatment market, globally
Geographically, the emerging Asian countries, such as China, India, Japan and Singapore, are offering high-growth opportunities for market players. The Asia Pacific point of care market is projected to grow at the highest CAGR of 6.5% from 2021 to 2026. Expansion of healthcare infrastructure and increase in disposable personal income, rising medical tourism in Asian countries, increasing healthcare expenditure, and growing awareness among people about the safe & effective shoulder arthroscopy treatment, presence of geriatric patient population with osteoarthritis and presence of players with robust rotator cuff injury treatment devices product portfolio are likely to contribute towards the significant the growth of the rotator cuff injury treatment market in the region.
Prominent players in this market are The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), FUJIFILM Irvine Scientific (US), Kitazato Corporation (Japan), and Hamilton Thorne Ltd. (US), among others.
Market Dynamics
Industry Growth Opportunities
- Rising number of sports-related shoulder injuries
- Rising technological advancements in rotator cuff rupture devices
- Growing public-private funding grants and educational awareness initiatives
- Increasing risk of osteoarthritis in the geriatric population
- Growing developments in orthobiologics
Burning Issues and Challenges
- High costs associated with arthroscopic surgery instruments
- High failure rates of rotator cuff treatment
- Shortage of trained orthopedic professionals
